Zevra Therapeutics, Inc. (ZVRA)
10.94
+0.62
(+6.01%)
USD |
NASDAQ |
May 27, 16:00
10.94
0.00 (0.00%)
After-Hours: 16:33
Zevra Therapeutics Free Cash Flow : 12.00M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Ocular Therapeutix, Inc. | -240.94M |
| Journey Medical Corp. | -6.775M |
| Corcept Therapeutics, Inc. | 119.79M |
| Assertio Holdings, Inc. | -7.081M |
| Johnson & Johnson | 17.80B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 6.142M |
| Cash from Investing (Quarterly) | 79.62M |
| Cash from Financing (Quarterly) | -52.80M |
| Free Cash Flow Per Share (Quarterly) | 0.1014 |
| Free Cash Flow to Equity (Quarterly) | 68.17M |
| Free Cash Flow to Firm (Quarterly) | 7.554M |
| Free Cash Flow Yield | 1.90% |